Molecular Partners AG (ADR)
General ticker "MOLN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $147.4M (TTM average)
Molecular Partners AG (ADR) does not follow the US Stock Market performance with the rate: -7.6%.
Estimated limits based on current volatility of 2.1%: low 4.28$, high 4.47$
Factors to consider:
- Total employees count: 163 as of 2021
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.46$, 7.75$]
- 2025-12-31 to 2026-12-31 estimated range: [2.96$, 6.85$]
Financial Metrics affecting the MOLN estimates:
- Positive: with PPE of -2.9 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -37.30 <= 0.33
- Positive: Investing cash flow per share per price, % of 25.49 > -0.66
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 0.02 <= 0.79
- Positive: Shareholder equity ratio, % of 89.35 > 63.39
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -16.34 <= 0
Short-term MOLN quotes
Long-term MOLN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | CHF189.56MM | CHF7.04MM | CHF4.97MM |
| Operating Expenses | CHF72.94MM | CHF68.15MM | CHF66.19MM |
| Operating Income | CHF116.61MM | CHF-61.11MM | CHF-61.22MM |
| Non-Operating Income | CHF1.24MM | CHF-0.88MM | CHF7.18MM |
| Interest Expense | CHF0.65MM | CHF0.05MM | CHF0.03MM |
| R&D Expense | CHF50.75MM | CHF48.78MM | CHF48.60MM |
| Income(Loss) | CHF117.85MM | CHF-61.98MM | CHF-54.04MM |
| Taxes | CHF0.00MM | CHF0.00MM | CHF0.00MM |
| Profit(Loss)* | CHF117.85MM | CHF-61.98MM | CHF-54.04MM |
| Stockholders Equity | CHF235.17MM | CHF176.43MM | CHF141.64MM |
| Assets | CHF262.26MM | CHF198.35MM | CHF158.53MM |
| Operating Cash Flow | CHF118.57MM | CHF-59.01MM | CHF-59.25MM |
| Capital expenditure | CHF1.42MM | CHF0.57MM | CHF0.72MM |
| Investing Cash Flow | CHF-101.12MM | CHF44.64MM | CHF40.49MM |
| Financing Cash Flow | CHF-1.57MM | CHF-1.17MM | CHF14.43MM |
| Earnings Per Share** | CHF3.63 | CHF-1.89 | CHF-1.59 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.